EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 23 May 2024

News

Pharmaceutical trade associations welcome latest announcement of largest number of regulatory...
21 May 2024

The WLA framework is crucial for regulatory convergence and harmonisation. Read more

Clinical Trials Day 2024

Lab of the future: when science and technology meet to deliver medicines faster in Europe
20 May 2024 - Henning Kleine

As science evolves, if you're just keeping up, you're already behind the curve. Read more

Advancing Clinical Trials for European Patients
16 May 2024 - Tom Metcalfe - Stefan Schwoch - Max Wegner

Now is the time to catalyse healthcare innovation – improving patients’ lives and restoring Europe as a powerhouse for... Read more

Open Letter ECRD 2024

Last week, we were honored to join ECRD 2024 and sign an open letter calling on the next European leaders to:

Maintain health at the forefront of future policies and programmes.
Develop a comprehensive European Action Plan for Rare Diseases that bridges diverse policy areas and streamlines existing efforts with clear, measurable objectives.
Immediately address the most pressing needs of the rare disease population by integrating the actions ‘within reach’ that we have collectively identified within the work programmes of the next years.

Read and sign the open letter here.

Events

IMI impact on antimicrobial resistance
31 May 2024 (Online event)

Combatting antimicrobial resistance: the legacy of the IMI COMBACTE projects. Read more

Countdown to the EU HTA: how can we seize this opportunity to improve patient access to medicines?...
04 June 2024 (Online session)

In January 2025, all new cancer medicines and advanced therapy medicinal products (ATMPs) will be jointly assessed at... Read more

Register for the webinar series "5 ways to reduce cancer care inequalities in Europe"

From May 27th to May 31st, 2024, CPE, EFPIA and IHE will host a series of webinars to discuss how to reduce cancer care inequalities in Europe.

Schedule:
May 27 - Prevention & Early Diagnosis
May 28 - Innovative Diagnostics & Accurate Diagnosis
May 29 - Innovation in Treatment
May 30 - Survivorship
May 31 - Smoking Cessation, a step towards a cancer-free environment

What we are reading

Beating cancer in Europe: A health priority within our grasp
On 22 May 2024 (Euractiv)

Greg Rossi discusses the imperative to address cancer in Europe with early detection,... Read more

Multiple Myeloma in Central Europe and the Baltics: Supporting early and equitable access to...
On 19 May 2024 (Economist Impact)

The advancements made in myeloma care are enviable, but are yet to reach a majority... Read more

Industry group pushes for more progress against antimicrobial resistance
On 06 May 2024 (CIDRAP)

In the political declaration that emerged from the 2016 United Nations(UN) High-Level... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu